You are once again, lying intentionally.
In May 2020, the Trump administration introduced a new Medicare Part D Senior Savings Model, which was set to start in 2021. This model aimed to cap the cost of insulin at $35 per month for Medicare beneficiaries. The Medicare Part D Senior Savings Model, which aimed to cap the cost of insulin at $35 per month, was expected to benefit a significant number of Medicare beneficiaries. According to the Centers for Medicare & Medicaid Services (CMS), this model had the potential to benefit over 1.6 million seniors who use insulin and are enrolled in Medicare Part D plans participating in the model. This initiative was part of a broader effort to make insulin more affordable and accessible for Medicare.